Organization: Health Canada
Year: 2022
Month: May
Request Number: A-2022-000074
Request Summary: Communications between Health Canada and Novartis Pharmaceuticals Canada Inc., or any other party, regarding any request to list Canadian Patent No. 2,822,701 on the Patent Register in relation to the medicinal ingredient trametinib and any decision relating to that request. Documents relating to Health Canada's decision not to list CA 2,822,701 on the Patent Register. Documents relating to the eligibility of CA 2,822,701 for listing on the Patent Register in relation to trametinib.
Disposition: No records exist
Number of pages: 0